We only have this paper's title and publication details.
Read it at the sourceAssesses efficacy of mogamulizumab in Sézary syndrome with Crohn’s disease, indicating its therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Raimondo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: